Target intelligence / Profile preview

DLGAP1 antisense RNA 3 (DLGAP1-AS3)

Target: DLGAP1-AS3
Molecular classification: Long non-coding RNA (lncRNA)

Overview

DLGAP1 antisense RNA 3 (DLGAP1-AS3) is a long non-coding RNA (lncRNA) gene, meaning it does not encode a protein product[4][5]. It is classified as an RNA gene within the lncRNA class and is currently associated with retinitis pigmentosa, a degenerative genetic eye disorder[5]. No specific biological function, disease mechanism, or therapeutic targeting has been experimentally validated or reported in current scientific literature for DLGAP1-AS3. This distinguishes it from other members of the DLGAP1 antisense RNA family, such as DLGAP1-AS1 and DLGAP1-AS2, which have been implicated in oncogenesis and cancer progression. Clinical or preclinical studies for DLGAP1-AS3 as a biomarker or drug target are currently lacking.

Other names: DLGAP1-AS3DLGAP1 antisense RNA 3 (non-protein coding)

Biological functions

Unknown (no published functional characterization or experimental biological activity currently associated)

Disease associations

Retinitis pigmentosaOther (uncertain/insufficient evidence in oncology or major disease roles)

Beyond the preview

Go deeper on DLGAP1 antisense RNA 3 (DLGAP1-AS3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DLGAP1 antisense RNA 3 (DLGAP1-AS3).

Explore the full profile